Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “neutral” rating and set a $5.00 price objective on shares of Trevena in a research note on Thursday, […]
Investment analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “neutral” rating and set a $5.00 price objective on shares of Trevena in a research note on Thursday, […]
